LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2025
DOI: 10.1016/j.plefa.2025.102680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2025. Verfasst von Yanling Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. Hauptthemen laut MEDLINE: Receptors, Leukotriene B4, Neutrophils, NADPH Oxidases, Leukotriene B4. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Västra Götaland Regional Executive Board, Rune and Ulla Amlövs Foundation, Wilhelm och Martina Lundgrens Stiftelser.
Abstract (Originalsprache)
The endogenous neutrophil chemoattractant leukotriene B4 (LTB4) is a biased signalling agonist that potently increases the intracellular concentration of free calcium ions ([Ca2+]i), but alone is a weak activator of the neutrophil superoxide anion (O2-)-generating NADPH oxidase. However, in this study we show that an allosteric modulator of the free fatty acid 2 receptor (FFA2R) converts LTB4 into a potent NADPH oxidase activating agonist. While an allosteric modulation of FFA2R was required for LTB4 receptor 1 (BLT1R)-mediated activation of the NADPH oxidase, the LTB4-induced increase in [Ca2+]i was not affected by the modulator. Thus, the biased BLT1R signalling pattern was altered in the presence of the allosteric FFA2R modulator, being biased with a preference towards the signals that activate the NADPH oxidase relative to an increase in [Ca2+]i. Both BLT1R and FFA2R belong to the family of G protein-coupled receptors (GPCRs), and our results show that a communication between the activated BLT1R and the allosterically modulated FFA2Rs generates signals that induce NADPH oxidase activity. This is consistent with a previously described receptor transactivation (crosstalk) model whereby the function of one neutrophil GPCR can be regulated by receptor downstream signals generated by another GPCR. Furthermore, the finding that an allosteric FFA2R modulator sensitises not only the response induced by orthosteric FFA2R agonists but also the response induced by LTB4, violates the receptor restriction properties that normally define the selectivity of allosteric GPCR modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, Unive…
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. Electronic address: martina.sundqvist@rheuma.gu.se.
Förderung
- Region Västra Götaland Regional Executive Board
- Rune and Ulla Amlövs Foundation
- Wilhelm och Martina Lundgrens Stiftelser
- IngaBritt and Arne Lundberg Foundation
- Foundation King Gustaf V 80-årsfond
- Foundation King Gustaf V Jubilee Fund
- Swedish Research Council
- Foundation Mary von Sydow born Wijk Donation Fund
Zitieren
APA
Wu, Y., Dahlgren, C., Forsman, H., & Sundqvist, M. (2025). LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. https://doi.org/10.1016/j.plefa.2025.102680
Vancouver
Wu Y, Dahlgren C, Forsman H, Sundqvist M. LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2025. doi:10.1016/j.plefa.2025.102680
BibTeX
@article{Wu2025,
author = {Wu, Yanling and Dahlgren, Claes and Forsman, Huamei and Sundqvist, Martina},
title = {LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2025},
doi = {10.1016/j.plefa.2025.102680}
}
EUVIMED